Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115248) titled 'A prospective, multicenter, randomized, treatment-controlled, double-blind, superiority clinical trial to evaluate the efficacy and safety of Sodium Hyaluronate Compound Solution for Injection' on Dec. 24, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Seventh Medical Center of the Chinese People's Liberation Army General Hospital
Condition:
Adults have dry, Dark skin
Intervention:
Experimental group:Injection treatment was carried out after randomization, with three consecutive injections, each with an interval of one month.
Recruitment Status: Not Recruiting
Phase: ...